Elmind Capital, LP
CIK 2052213 · 在 SEC EDGAR 上查看 ↗
- 投资组合价值
- $398.0M
- 持仓
- 35
- 截至
- 2026年6月30日
按 13F 价值排名第 4380（共 9443） · 前 46.4%
投资组合价值同比（季度）：+13.0% 13F不披露现金
- 前十大持仓权重
- 66.60%
- 前二十五大持仓权重
- 96.13%
- 持仓高于 1%
- 23
- 有效持仓数量
- 17.0
仅基于13F多头股票持仓（现金、债券、空头未披露）
周转率 Q2 2026: 19.49% 估计买入 $86097503 · 卖出 $73128681
- 新仓位
- 6
- 增加
- 9
- 减少
- 6
- 已结清
- 5
本页内容
与标普500指数的表现对比
近似于基于季度SEC 13F快照构建的买入并持有投资组合。不包括现金、空头头寸、期权/衍生品和非13(f)证券——仅反映已披露的多头股票账簿，而非基金总资产管理规模。SEC文件延迟最多可达45天；这不是一个可实时复制的交易。
可定价覆盖率：95.2% · 已排除期权：0.0%
行业细分
Healthcare
99.9%
其他/未映射
0.1%
完整投资组合 35 持仓
| 类型 | 连胜 | 8个季度趋势 | |||||
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences, Inc. - Common Stock | $45307638 | 11.38% | 1170740 | $245855 | |||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $40550300 | 10.19% | 1855000 | $-2782500 | |||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $36837900 | 9.25% | 990000 | $9400100 | 上涨 ×1 | ||
| RLAY Relay Therapeutics, Inc. - Common Stock | $27415370 | 6.89% | 1465279 | $22072757 | 上涨 ×1 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $26294524 | 6.61% | 452340 | $7902709 | 上涨 ×2 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $18730987 | 4.71% | 436518 | $-679988 | 下跌 ×1 | ||
| PHVS Pharvaris N.V. - Ordinary Shares | $18180435 | 4.57% | 525750 | $4740497 | 上涨 ×1 | ||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $18093182 | 4.55% | 984931 | $7629932 | 上涨 ×1 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $17062500 | 4.29% | 4550000 | $-4322500 | |||
| TVTX Travere Therapeutics, Inc. - Common Stock | $16622606 | 4.18% | 292600 | $11346110 | 上涨 ×2 | ||
| LEGN Legend Biotech Corporation - American Depositary Shares | $16478033 | 4.14% | 570569 | 上涨 ×1 | |||
| BEAM Beam Therapeutics Inc. - Common Stock | $16347920 | 4.11% | 476338 | $4996785 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $12564900 | 3.16% | 690000 | $5033600 | 上涨 ×2 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $11159600 | 2.80% | 460000 | $4029600 | |||
| KRYS Krystal Biotech, Inc. - Common Stock | $8176740 | 2.05% | 22000 | $2493700 | |||
| UTHR United Therapeutics Corporation - Common Stock | $8127450 | 2.04% | 15000 | $-767250 | |||
| SMMT Summit Therapeutics Inc. - Common Stock | $7194957 | 1.81% | 493820 | 上涨 ×1 | |||
| INSM Insmed Incorporated - Common Stock | $6930300 | 1.74% | 65000 | 上涨 ×1 | |||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $5200000 | 1.31% | 520000 | $-4320000 | 下跌 ×2 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $5023200 | 1.26% | 91000 | $-1275150 | 下跌 ×1 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $4658040 | 1.17% | 38000 | $652840 | |||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $4416000 | 1.11% | 120000 | $460400 | 下跌 ×1 | ||
| DBVT DBV Technologies S.A. - American Depositary Shares | $4346000 | 1.09% | 265000 | $-1189850 | |||
| ALMS Alumis Inc. - Common Stock | $3658200 | 0.92% | 130000 | $794300 | |||
| SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $3255700 | 0.82% | 70000 | $2221900 | 上涨 ×1 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $2689340 | 0.68% | 47000 | $34310 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $2576290 | 0.65% | 81143 | $820113 | 上涨 ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $2011520 | 0.51% | 112000 | $454720 | |||
| ALEC Alector, Inc. - Common Stock | $1809000 | 0.45% | 900000 | $-126000 | |||
| SEPN Septerna, Inc. - Common Stock | $1655880 | 0.42% | 49444 | 上涨 ×1 | |||
| DSGN Design Therapeutics, Inc. - Common Stock | $1561313 | 0.39% | 107900 | $-650743 | 下跌 ×1 | ||
| STRO Sutro Biopharma, Inc. - Common Stock | $1063628 | 0.27% | 32037 | 上涨 ×1 | |||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $1033285 | 0.26% | 177846 | $-256099 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $638800 | 0.16% | 20000 | $-12766200 | 下跌 ×1 | ||
| 未知发行人 (CUSIP: 29286X101) | $363300 | 0.09% | 210000 | 上涨 ×1 | |||
| 无匹配项 | |||||||
最大新仓位
本季度新开仓位，按规模从大到小排序。
季度涨幅榜
| 证券 | 操作 | 股份变动 | 价值变动 |
|---|---|---|---|
| TVTX | 增持 | +115K | +$11.3M |
| CLDX | 增持 | +125K | +$9.4M |
| PCVX | 增持 | +136K | +$7.9M |
| VRDN | 增持 | +450K | +$7.6M |
| CGEM | 增持 | +160K | +$5.0M |
| BEAM | 仅价格变动 | +0 | +$5.0M |
| PHVS | 增持 | +50K | +$4.7M |
| CTMX | 仅价格变动 | +0 | -$4.3M |
| BCRX | 削减 | -480K | -$4.3M |
| NRIX | 仅价格变动 | +0 | +$4.0M |
2 个持仓已隐藏（数据完整性检查）
已退出持仓
包含公司事件（合并、退市）——并非所有退出都是卖出
已关闭的头寸反映了 13F 报告的变更；对于指数管理人来说，这些通常是机械性的（退市、并购、指数再平衡），而不是主动决策。